• Mavorixafor: A Translational CXCR4 Playbook

  2026-08-28

  A mechanistic and strategic guide to using Mavorixafor hydrochloride (AMD-070 hydrochloride) in CXCR4 biology, immune-cell trafficking, anti-HIV research, and exploratory cross-domain studies informed by tissue-perfusion research.

• G-15: G Protein-Coupled Estrogen Receptor Antagonist

  2026-08-27

  G-15 helps separate GPR30-driven estrogen responses from classical ERα and ERβ signaling in calcium, PI3K/Akt, proliferation, and immune-cell workflows. This guide translates a hemorrhagic-shock study into practical assay design, dosing, controls, and troubleshooting strategies.

• MK 0893 Glucagon Receptor Antagonist

  2026-08-27

  MK 0893 is a competitive, reversible glucagon receptor antagonist that blocks human GCGR signaling through an extra-helical allosteric site. Its nanomolar binding and cAMP potencies support cell-based mechanism studies and translational type 2 diabetes research.

• Radiocleavable Nanoparticles in Pancreatic Cancer

  2026-08-26

  Gupta et al. describe a folate receptor-guided LiYF4:Ce3+ nanoparticle system that uses radiation-responsive intracellular release to promote ferroptosis, mitochondrial injury, and immunogenic cell death in pancreatic cancer. The study supports a treatment concept that combines tumor-cell targeting with oxidative damage and remodeling of the immune-suppressive microenvironment, while also defining important validation steps for translation.

• Tunable Human Intestinal Organoids Balance Cell Fate

  2026-08-26

  The reference study develops a human small intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity under a single culture condition. Its central innovation is to strengthen stem-cell competence first, then use BMP, Wnt, Notch, and BET-linked signals to tune lineage output without constructing artificial spatial or temporal gradients.

• NADH Redox Strategy for Translational Research

  2026-08-25

  NADH is more than an electron donor: it is a controllable lens on metabolic state, mitochondrial function, and redox vulnerability. This thought-leadership guide connects mechanistic biology with practical study design across diabetic nephropathy research, mitochondrial electron transport chain research, disease modeling, and emerging photocatalytic cancer therapy.

• Lysosomal β-Galactosidase Staining Kit in Senescence

  2026-08-25

  The Lysosomal β-Galactosidase Staining Kit K2181 enables rigorous interpretation of lysosomal activity in senescence research. This guide connects chromogenic control staining with the SLC25A1–senescence mechanism reported in HNSCC cisplatin resistance studies.

• Berbamine Hydrochloride: A Ferroptosis-Ready Probe

  2026-08-24

  A translational framework for using Berbamine hydrochloride to connect STAT3, calcium homeostasis, NF-κB signaling pathway inhibition, and ferroptosis-resistance biology in leukemia and hepatocellular carcinoma models.

• GLP-1 (9-36) Amide: A Signaling Control Tool

  2026-08-23

  GLP-1 (9-36) amide provides a focused pharmacological perturbation for separating GLP-1 receptor activity from ligand cross-reactivity. This article presents an assay-centered framework for receptor deconvolution, peptide handling, and interpretation in metabolic research.

• Dextromethorphan Hydrobromide: Assay Logic

  2026-08-22

  Dextromethorphan hydrobromide is a versatile NMDA receptor antagonist for dissecting excitotoxic injury, ion-channel modulation, and neuroprotection research. This article presents an evidence-centered framework for choosing assays, interpreting protection, and translating findings without confusing pharmacological control data with therapeutic claims.

• Griseofulvin: Microtubule Assay Workflow

  2026-08-21

  Griseofulvin provides a practical perturbation tool for connecting fungal cell mitosis inhibition with microtubule mechanism studies. This workflow emphasizes solvent control, time-resolved phenotyping, and orthogonal readouts so antifungal drug research can distinguish target engagement from nonspecific toxicity.

• Nanobody Swapping for Precision AAV Tropism

  2026-08-20

  This 2024 study identifies multiple AAV-DJ capsid hotspots that tolerate nanobody insertion and enable modular retargeting without extensive capsid optimization. Its comparison of VP1 and VP2, together with FAP-directed targeting and heparin-binding domain ablation, provides a practical framework for improving cell specificity while preserving vector production and infectivity.

• Nuclear cGAS Restricts L1 Retrotransposition

  2026-08-20

  The reference study identifies a nuclear cGAS–CHK2–TRIM41 pathway that limits LINE-1 retrotransposition by promoting ubiquitination and degradation of ORF2p. Its findings connect DNA damage signaling with post-translational control of mobile genetic elements, offering a mechanistic framework for genome-integrity and cancer research.

• Mestranol and Reversible Lysosomal Stress in Microglia

  2026-08-19

  The reference study identifies mestranol as an inducer of a reversible lysosomal storage–like state in zebrafish microglia, separating impaired intracellular digestion from defects in phagocytic uptake or neuronal survival. Its live-animal model and transcriptional analysis provide a framework for studying environmental estrogen-associated neuroimmunotoxicity and for designing orthogonal apoptosis and lysosomal stress measurements.

• Vitamin Docking Targets in SARS-CoV-2: What the Study Shows

  2026-08-19

  This 2022 molecular modeling study examined natural vitamin compounds against two SARS-CoV-2 vulnerabilities: the spike receptor-binding domain and the 3CLpro main protease. Its dual-target docking and molecular dynamics strategy identified several candidates with apparently stable interactions, but the findings remain hypothesis-generating and require biochemical, cellular, pharmacokinetic, and clinical validation.

459 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page